[TLX] YoY Quarter Result on 31-Jan-2017 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Jan-2017
Financial Year
2016
Quarter
31-Jan-2017 [#Q4]
Profit Trend
QoQ- -2,257.58%
YoY- -2,257.58%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/01/17 31/12/15 30/09/00 31/01/00 CAGR
Revenue 1,667 195 49 0 0 0 0 -
PBT -25,690 -10,524 -4,806 -1,594 -66 -249 -124 30.68%
Tax -8,192 1,884 -471 -38 -8 -249 -124 23.40%
NP -17,497 -8,640 -4,806 -1,556 -66 -497 0 -
Tax Rate - - - - - - - -
Total Cost 19,165 8,835 4,854 1,556 66 497 0 -
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/01/17 31/12/15 30/09/00 31/01/00 CAGR
NP Margin -1,049.33 -4,430.77 -9,850.62 0.00 0.00 0.00 0.00 -
Per Share
31/12/19 31/12/18 31/12/17 31/01/17 31/12/15 30/09/00 31/01/00 CAGR
EPS -0.07 -0.04 -0.02 -0.01 0.00 -0.01 0.00 -
EPS Diluted -0.07 -0.04 -0.02 -0.01 0.00 -0.01 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.